NEW YORK (GenomeWeb) – Becton Dickinson today reported a nearly 40 percent jump in its fiscal fourth quarter revenues, reflecting the company's acquisition of medical technology firm CareFusion earlier this year.

"We are very pleased with our strong finish to the year as a combined entity," BD CFO Christopher Reidy said during a conference call after the release of the company's earnings. "We significantly expanded our margins and captured approximately $50 million in synergy cost savings." 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.